Navigation Links
Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
Date:5/9/2008

ovision (3) 7.5% to 8% of EBTA 5.5% to 6.5% of EBTA

GAAP Net Income $118 to $128 $129 to $142

Cash Net Income ("CNI") (4) $315 to $325 $326 to $339

CNI per share (4) (5) $1.25 to $1.30 $1.30 to $1.35

(1) Revised guidance assumes generic competition for DOVONEX solution and

SARAFEM in 2Q08. Guidance does not account for the impact of any future

new licensing agreements.

(2) Total SG&A expense does not include any amount that may be payable in

connection with the potential settlement of our outstanding legal actions.

(3) The total 2008 tax provision is estimated as a % of earnings before

taxes and book amortization ("EBTA").

(4) A reconciliation of 2008 GAAP net income to CNI adds back the expected

after tax impact of amortization of intangibles ($189M) and the expected

after tax impact of deferred financing fees ($8M).

(5) CNI per share is based on 251.0 million fully diluted Class A shares.


'/>"/>
SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
2. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
6. Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
7. Warner Chilcott Reports the Death of Its Director James Andress
8. Mark Whitacre, Ph.D. Promoted at Cypress Systems, Inc. and a Warner Brothers Movie to Be Filmed About Him
9. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. QMed, Inc. Reports July Medicare SNP Enrollments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 RURO Inc. ... version 4.1, a versatile refinement to the smart ... solution, improves its advanced methodical management for transgenic ... ezColony 4.1. The network-based platform provides user access ... research. While continuing to emphasize streamlined tasks, such ...
(Date:5/17/2013)... IAC Industries wants to share with you ... needing to set up and furnish a research lab knowing ... within a year’s time. How does a company make choices ... temporary? What is efficient and cost-effective? , The solution ... Industries. The planners at DisperSol determined that the concept of ...
(Date:5/16/2013)... 2013 The Stirling Ultracold Model ... Inc., Athens, OH, USA, won the Outstanding New Product ... Society for Biological and Environmental Repositories (ISBER) at their ... one product annually, recognizes the company’s development and introduction ... The award was presented to Global Cooling’s CEO ...
(Date:5/16/2013)... Oven Industries, Inc. has been an ... temperature sensors since 1964. Expertly designed, the proportional-integral-derivative ... system applications. As one of the most ... control loop feedback system, which helps minimize errors. With ... a systematic process, using a control element, like a ...
Breaking Biology Technology:RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2New PID Temperature Controllers Announced by Oven Industries Inc. 2
... Inc. (Nasdaq: CVTX ) today advised its ... response to Astellas Pharma Inc.,s announcement that its indirect ... offer for all outstanding common shares of CV Therapeutics ... CV Therapeutics, board of directors, in consultation with ...
... Morningstar, Inc. (Nasdaq:, MORN ), a leading provider ... institutional investors including portfolio managers at,mutual funds, hedge funds, ... Top 15 Biotech Acquisition Targets" and it will be ... March 4. , Damien Conover, ...
... /PRNewswire-Asia/ -- China Medicine Corporation,(OTC Bulletin ... Company"), a leading,distributor and developer of ... ("TCM"), nutritional and dietary supplements,medical devices, ... Republic of China,("PRC"), through its wholly-owned ...
Cached Biology Technology:CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer 2CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer 3Morningstar Healthcare Analysts to Discuss Top 15 Biotech Acquisition Targets on Wednesday, March 4 at 11 a.m. EST 2China Medicine to Participate in 2009 Natural Products Expo West Trade Show 2China Medicine to Participate in 2009 Natural Products Expo West Trade Show 3
(Date:5/16/2013)... can trigger hematopoiesis at sites outside the bone marrow ... of Ludwig-Maximilians-Universitaet (LMU) in Munich now show that a ... formation of blood cells. , Balanced hematopoiesis is essential ... development, hematopoiesis takes place mainly in the liver and ... bone marrow, and this tissue normally serves as the ...
(Date:5/16/2013)... don,t ponder our pulses outside of the gym. But doctors ... heart health. , Zhenan Bao, a professor of chemical engineering ... dollar bill and no wider than a postage stamp. The ... wrist, is sensitive enough to help doctors detect stiff arteries ... used to continuously track heart health and provide doctors a ...
(Date:5/15/2013)... "keystone" molecules that have powerful behavioral effects on ... in structuring ecosystems, according to a theory proposed ... The authors of the theory, Ryan P. Ferrer ... of the University of California at Los Angeles, ... plants that may be uncommon but exert a ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Natural 'keystone molecules' punch over their weight in ecosystems 2
... is a medically important fungus, causing potentially life-threatening infections ... a major cause of respiratory allergy, and it is ... been thought to lack the ability to reproduce sexually, ... indicate that the fungus has a number of characteristics ...
... a genetic study has followed a single humpback whale ... notions of the migratory patterns of these majestic marine ... Wildlife Conservation Society (WCS), the American Museum of Natural ... recent Royal Society's Biology Letters, a male humpback whale ...
... efficiently after injury. But when they don't, otherwise ... surgery or trauma can be stymied. Furthermore, as ... Duchenne Muscular Dystrophy and other degenerative muscle diseases, ... , Researchers from the University of Illinois-Chicago (UIC) ...
Cached Biology News:Secret sex life of killer fungus? 2Genetics links whale to two different ocean basins 2Muscle repair: Making a good system better, faster; implications for aging, disease 2Muscle repair: Making a good system better, faster; implications for aging, disease 3Muscle repair: Making a good system better, faster; implications for aging, disease 4
... glycoprotein. distributed in colon and rectum, ... lung and salivary gland tissues. ... and MUC2. Epitope: Tandem repeats ... MUC3 tandem repeat peptide Positive ...
... This immunoaffinity purified antibody detects an ... molecular mass of ErbB-2 phosphorylated at tyrosine ... product has been cross adsorbed against the ... detect the non-phosphorylated form of the protein. ...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
...
Biology Products: